MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

MDT

95.32

-0.85%↓

136.54

+0.26%↑

VEEV

222.01

-0.49%↓

HQY

91.23

-0.31%↓

PHR.US

16.68

-1.3%↓

Home・Aandelen Lijst・CEL-SCI Corp

CEL-SCI Corp

Gesloten

SectorGezondheidszorg

5.09 -2.68

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

5.05

Max

5.22

Belangrijke statistieken
By Trading Economics
Inkomsten	908K -5.7M
EPS	-1.36
EBITDA	890K -4.5M

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-6.4M 42M
Vorige openingsprijs	7.77
Vorige sluitingsprijs	5.09

Nieuwssentiment

By Acuity

57%

43%

300 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

N/A / 0.2494 Steun & Weerstand

CEL-SCI Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 dec 2025, 22:20 UTC

Belangrijke Marktbewegers

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dec 2025, 17:31 UTC

Belangrijke Marktbewegers

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dec 2025, 16:30 UTC

Belangrijke Marktbewegers

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dec 2025, 15:19 UTC

Belangrijke Marktbewegers

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dec 2025, 15:17 UTC

Belangrijke Marktbewegers

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dec 2025, 14:37 UTC

Belangrijke Marktbewegers

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

1 jan 2026, 23:35 UTC

Marktinformatie

Gold Rises Amid Geopolitical Risks -- Market Talk

1 jan 2026, 21:29 UTC

Acquisities, Fusies, Overnames

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

1 jan 2026, 21:29 UTC

Acquisities, Fusies, Overnames

BlueScope Sold Stake in JV to Tata Steel

1 jan 2026, 21:28 UTC

Acquisities, Fusies, Overnames

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

1 jan 2026, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

1 jan 2026, 09:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

31 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

31 dec 2025, 21:13 UTC

Acquisities, Fusies, Overnames

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dec 2025, 20:40 UTC

Marktinformatie

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dec 2025, 20:22 UTC

Marktinformatie

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dec 2025, 19:50 UTC

Marktinformatie

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dec 2025, 19:31 UTC

Marktinformatie

Precious Metals Cap Off Record Runs -- Market Talk

31 dec 2025, 18:50 UTC

Marktinformatie

Global Equities Roundup: Market Talk

31 dec 2025, 18:50 UTC

Marktinformatie

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dec 2025, 17:17 UTC

Marktinformatie

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dec 2025, 17:16 UTC

Belangrijke Marktbewegers

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dec 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

31 dec 2025, 17:00 UTC

Acquisities, Fusies, Overnames

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dec 2025, 15:57 UTC

Acquisities, Fusies, Overnames

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dec 2025, 15:54 UTC

Marktinformatie

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dec 2025, 15:02 UTC

Belangrijke Marktbewegers

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dec 2025, 14:40 UTC

Acquisities, Fusies, Overnames

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dec 2025, 14:20 UTC

Marktinformatie

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dec 2025, 13:46 UTC

Marktinformatie

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Peer Vergelijking

Prijswijziging

CEL-SCI Corp Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan CEL-SCI Corp - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

N/A / 0.2494Steun & Weerstand

Recent bearish events outweigh bullish events.

There is one bullish event.

There is one bearish event.

Sentiment

By Acuity

300 / 374 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Andere aandelen uit de sector

MDT

Medtronic PLC

95.32

↓-0.85%

Agilent Technologies Inc

136.54

↑ +0.26%

VEEV

Veeva Systems Inc

222.01

↓-0.49%

HQY

HealthEquity Inc

91.23

↓-0.31%

PHR.US

Phreesia Inc

16.68

↓-1.3%

CEL-SCI Corp

Overzicht

Wijziging aandelenprijs

Belangrijke statistieken

Marktinformatie

Nieuwssentiment

Technische score

CEL-SCI Corp Grafiek

Gerelateerd nieuws

Peer Vergelijking

CEL-SCI Corp Prognose

Beoordelingsconsensus

Technische score

Sentiment

Financieel

Andere aandelen uit de sector